If you’ve been in psychiatry long enough to have a favorite drug reference, there’s a reasonable chance it’s Carlat. The Medication Fact Book for Psychiatric Practice has been a quiet fixture on the desks of psychiatrists, nurse practitioners, and PAs for years — and the Eighth Edition (2026), written by Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP, landed this winter.
If you’re running a solo or small-group PMHNP practice, this is worth a few minutes of your attention. Not because reference books are exciting (they aren’t), but because the one you lean on every day shapes the speed and confidence of your prescribing. Here’s what changed, what actually matters, and how to decide whether the new edition — or the companion Toolkit web app — is worth the spend for your practice.
Why Carlat Still Gets the Recommendation
Carlat Publishing is one of the few psychiatric education sources that publishes independent of pharmaceutical industry funding. That’s their founding principle and it’s printed on every issue. For a PMHNP in private practice — where you don’t have a pharmacy consult down the hall or grand rounds to sanity-check what a rep told you last Tuesday — that independence matters. You get a genuine opinion instead of a lightly reformatted slide deck.
The format is also unusually well-suited to the realities of our work. Single-page fact sheets. Treatment algorithms. Side-effect tables you can actually scan between patients. If you’ve ever flipped through Stahl’s in the middle of a visit, you know what I mean — Stahl’s is magnificent, but it’s not what you reach for when a patient asks about a bupropion-varenicline combination and you’ve got four minutes before the next session.

What’s New in the 8th Edition
Per the publisher page, the 2026 edition contains 179 fact sheets — a solid bump from prior editions — and includes newer additions that were missing from older printings. Cobenfy (xanomeline-trospium) is in there, which matters because patients are asking about it and most of us don’t have it on our fingertips the way we do for risperidone or olanzapine.
Other structural changes worth noting:
- 33 updated reference tables. The quick-scan tables are the backbone of the book, and tables on interactions, pharmacokinetics, and receptor profiles have been refreshed.
- 11 treatment algorithms, including a new Bipolar Depression Treatment Algorithm. This is welcome. Bipolar depression remains one of the trickier corners of outpatient psychiatry, and most published algorithms are either dated or buried deep in a 50-page guideline document.
- 29 patient education PDFs. These are genuinely useful for informed consent and for answering the “what should I read about this med?” question at the end of a visit.
- Redesigned layout that the publisher describes as easier to scan. Cosmetic, but real — the older editions could get dense in places.
- 12 AMA PRA Category 1 CME credits available through the accompanying post-test, if that’s useful for your licensing or certification cycle.
Carlat and Puzantian continue to give each medication a bottom-line assessment — a brief, plain-English take on where a drug fits in your toolbox and whether it’s worth using. That editorial voice is the main reason clinicians keep coming back. You don’t get that in the FDA label, and you don’t really get it in a UpToDate article that’s been sanded down by committee.
The Toolkit App: New, Useful, and Worth a Closer Look
Alongside the 8th Edition, Carlat launched the Carlat Psychiatry Toolkit, a subscription web app. This is new — it didn’t exist in prior editions — and it genuinely changes the calculus for anyone who wants a reference at the point of care.
The Toolkit combines fact sheets from the Medication Fact Book with content from six other Carlat clinical references into a single searchable library. Crucially, it’s updated continuously as new medications are approved, guidelines change, and new research reshapes best practices. For the print book, you wait two years for the next edition. For the Toolkit, you get updates as Carlat publishes them — and they add new fact sheets based on content from The Carlat Psychiatry Report newsletter.
If you bundle the book with Toolkit access, you get 40% off the first year. The combined package lands under $200, which is about the cost of two missed-claim denials you’d have written off anyway.

Why This Matters More for PMHNPs in Private Practice
If you’re employed in a hospital or large group, you have institutional access to resources. UpToDate is a line-item on the IT budget. If you’re solo — or running a practice with one or two other clinicians — every clinical reference is a purchase decision. And every hour you spend digging through six different sources to confirm a dose conversion is an hour you’re not billing, documenting, or sleeping.
A few specific situations where the new edition earns its keep:
When a patient brings in a medication you don’t prescribe often. The single-page layout means you can look up a drug during a brief between-patient break and walk back into the room sounding prepared. That’s professional polish — and it matters when patients are comparing you to their previous prescriber.
When you’re deciding whether to add a newer agent to your formulary. Should Cobenfy be part of your practice? What about newer TRD augmentation options? Carlat gives you a pragmatic read rather than marketing copy. That saves you from being either the first person to prescribe something experimental or the last person to adopt something useful.
During cross-tapers and switches. The algorithm pages and side-effect tables are laid out for the kind of decisions you make weekly: switching from an SSRI to an SNRI, augmenting a partial responder, or tapering a benzodiazepine without destabilizing a patient. Having the key numbers on one spread is faster than clicking through four browser tabs.
For patient education. The 29 patient fact sheets are a quiet gift. Hand one to a patient at the end of a visit and you’ve just improved adherence, reduced callback volume to your office, and strengthened your informed-consent documentation. Your MA or biller — if you have one — will thank you.
What I’d Skip and What I’d Actually Buy
Not everything in the 8th Edition is essential to every practice. If you prescribe twenty medications 95% of the time (as most of us do), the incremental value of 179 fact sheets versus, say, 120 is modest. You probably don’t personally need the obscure anticonvulsants or the rarely-used anxiolytics.
Here’s how I’d think about the buying decision:
- If you already own the 7th Edition (2024), the jump to the 8th is meaningful but not urgent. Consider the PDF/eBook version rather than waiting another two years. The Bipolar Depression Algorithm and the Cobenfy fact sheet alone are worth the price for many prescribers.
- If your current reference is older than the 7th Edition, upgrade now. The field has moved enough in recent years — TRD options, novel antipsychotics, revised ADHD guidance, deprescribing frameworks — that relying on older data is a quiet risk to your prescribing.
- If you’re new to private practice or in your first couple of years as a PMHNP, this should be a non-negotiable purchase. Lean on the print edition to build your reference fluency. Pick up the Toolkit if you want the continuous updates.
- If you’re high-volume or see a lot of complex patients, the Toolkit subscription is probably where the real value sits. A point-of-care searchable reference, updated as new data drops, on whatever device you happen to be on — that’s a different workflow than flipping to page 142.

A Note on Keeping Your Clinical Reference Library Independent
One of the quietly important moves a PMHNP in private practice can make is to build a reference library that isn’t dependent on pharmaceutical industry funding. It’s not that every industry-funded resource is biased — it’s that you shouldn’t have to spend mental energy filtering bias out of your daily tools.
Carlat is one of those independent sources. So is The Medical Letter, NIMH clinical content, and peer-reviewed summaries in JAMA Psychiatry or The American Journal of Psychiatry. The APA practice guidelines — currently being updated for depression under a panel the APA Board appointed in 2025 — are another anchor. Build your stack around those and you’ll rarely have to second-guess where a recommendation came from.
If you already subscribe to The Carlat Psychiatry Report newsletter, adding the Medication Fact Book and the Toolkit is incremental — you’re already in the ecosystem. If you don’t, the full stack (newsletter + book + Toolkit) is arguably the best independent psychopharmacology resource currently available for under a few hundred dollars a year.
The Honest Downside
A few things to keep in mind before you click buy:
- It’s a psychiatry reference, not a nursing reference. The language and framing assume a prescribing mindset, which works perfectly well for PMHNPs, but a brand-new NP may want something like Varcarolis alongside it for the broader nursing framework.
- The 8th Edition is heavy on pharmacology, light on business operations. That’s by design, not a criticism — but it means this book doesn’t help you with credentialing, coding, or compliance. You’ll still need separate resources for the business side of your practice.
- The Toolkit is subscription-based. If you hate recurring charges, the print-only version still gets you roughly two years of solid reference before the next edition hits.
- It’s not a substitute for primary literature. For the hard cases — the complicated augmentations, the unusual drug interactions, the off-label indications — you’ll still want to go to the source. The Fact Book is a map, not the terrain.
Bottom Line
The 2026 edition doesn’t reinvent the Medication Fact Book, and it doesn’t need to. What it does is refresh a reference that a lot of us already trust, add the newer medications our patients are asking about, and — finally — offer a live-updating app for clinicians who want something closer to point-of-care use than a print reference can provide.
For a PMHNP running a private practice, the calculus is simple. If you write prescriptions for a living, you should have an independent, current, well-organized reference within arm’s reach at every visit. Whether that lives on your desk, your tablet, or both is a personal preference. What matters is that you’re not reaching for whatever landed in your inbox from a pharmaceutical rep the week prior.
The 8th Edition is a sound upgrade. The Toolkit is the more interesting product story. And together, they’re a reasonable answer to a question most of us should be asking anyway: what does my clinical reference stack actually look like in 2026, and is it built on independent sources?
If you’re working on building out the reference library, clinical workflow, and business systems of a private PMHNP practice, we publish more practical guides on pmhnpwebsite.com — from credentialing and billing to the tools that actually save you time in a day of back-to-back visits.
